KL and diabetic kidney disease: Notably, adipose-tissue-derived MSCs (AT-MSCs) injected into animals with streptozotocin-induced renal injury, e.g., DKD, prevented the progression of kidney disease by decreasing Bax and Wnt/β-catenin levels, and increasing Bcl-2 and Klotho levels [266].